claim: phase 1 trial of a candidate recombinant virus-like particle vaccine for covid-19 disease produced in plants
evidence_1: added value of this study we report the results of the first clinical study of covlp, a virus-like particle (vlp) vaccine that is produced by transient transfection of nicotiana benthamiana plants.